From reliance to resilience: Minister Joly outlines Budget 2025 investments to Buy Canadian and build up Canada’s industrial strength

The Government of Canada is building the strongest economy in the G7-an economy rooted in Canadian workers, Canadian materials and Canadian innovation. As global trade becomes more uncertain, we are choosing to build our strength at home. Today, while touring KF Aerospace's facility in Hamilton, Ontario, the Honourable Mélanie Joly, Minister of Industry and Minister […]

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Perrigo Company plc (PRGO) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Perrigo Company plc ("Perrigo" or "the Company") (NYSE:PRGO). Investors who purchased Perrigo securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/PRGO.

Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. (INSP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), have until January 5, 2026 to seek appointment as lead plaintiff of the Inspire Medical class action

Eight out of 10 infants and newborns in Canada have access to RSV prevention with Beyfortus® this season

— Six provinces and three territories to provide universal immunization programs for RespiratorySyncytial Virus (RSV) infant protection this respiratory season — Beyfortus will also be reimbursed through select private health insurance providers — Beyfortusdemonstrated the ability to reduce the risk of RSV lower respiratory tract infections by 74.5%, including hospitalizations in infants entering their first

Trimble Highlights AI Strategy and Innovation at Dimensions User Conference

New Agentic AI Platform and AI Capabilities Help Customers Break Down Data Silos to Unlock Productivity – A Force Multiplier in Solving Real World Customer Problems at Scale Trimble (Nasdaq: TRMB) today gave attendees of its annual user conference, Trimble Dimensions, a firsthand look at artificial intelligence (AI) innovation and the company's vision for accelerating

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens Corning – OC

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Owens Corning ("Owens Corning" or the "Company") (NYSE:OC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Owens Corning and certain of its officers

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc. – ZBH

NEW YORK CITY, NY / ACCESS Newswire / November 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE:ZBH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Zimmer Biomet and certain of

EuroDry Ltd. Sets Date for the Release of Third Quarter 2025 Results, Conference Call and Webcast

(NASDAQ:EDRY), ATHENS, Greece, Nov. 10, 2025 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it will release its financial results for the third quarter ended September 30, 2025, on November 13, 2025 before market

IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer

(NASDAQ:IMNN), Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today hosted a compelling public webcast, where cancer key opinion leaders, principal investigators from the Phase 3 OVATION 3 and Phase 2 minimal residual

Matthews Announces the Return of Tiffany Hsiao as a Portfolio Manager to Strengthen Investment Leadership in Key Growth Areas

SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) — Matthews, a privately owned boutique investment management firm focused on Emerging Markets and Asia, today announced that Tiffany Hsiao has rejoined the firm. Tiffany's return supports Matthews' long-term strategy to deepen its expertise in key growth areas including China, technology and innovation. Tiffany brings extensive investment expertise

Scroll to Top